Core A: Administrative
Core A: Administrative
批准号:
10165492
负责人:
James L Riley
金额:
$8.09万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-05-15 至 2025-04-30
关键词:
Acquired Immunodeficiency SyndromeAdherenceAdministratorAdvisory CommitteesAnnual ReportsAwardBLT miceBasic ScienceBiometryBudgetsCAR T cell therapyClinicalClinical TrialsCommunicationCongressesEnsureGenomeGoalsGovernment AgenciesGuidelinesHIVHIV-1HomeHuman ResourcesImmunologyIndividualLaboratoriesLogisticsMissionModelingModificationMonitorNational Institute of Allergy and Infectious DiseaseOccupational activity of managing financesOutcomePharmacologic SubstancePhase I Clinical TrialsPreparationPrincipal InvestigatorPrivate SectorProductivityProgress ReportsPublicationsReportingResearchResearch PersonnelResource AllocationScientistStructureT cell responseT-LymphocyteTestingTherapeuticTimeTimeLineUnited States National Institutes of HealthViral reservoirWorkantiretroviral therapybench to bedsideclinical centerclinical epidemiologyclinical trial implementationdata managementdata sharingdesignengineered T cellsexperiencegenome analysisinnovationmanufacturing processmeetingsnovel strategiespreclinical evaluationprogramstargeted nucleasestooltraffickingworking group
中文摘要
点击翻译按钮获取中文摘要
英文摘要
CORE A: ABSTRACT
Core A will be responsible for providing administrative and biostatistics support for the overall
program project. The Core will interact with Program management at NIAID and with the
external Scientific Advisory Panel, coordinating meetings and progress reports. Budget reports
and annual reports to NIH and FDA will be coordinated by Core A. It will also serve to
amalgamate the investigators, their experimental findings and their ideas, evaluation of pre-
clinical and clinical efforts to focus efforts on enhancing the clinical outcome. The administrative
functions will be accomplished using a structure in which the Core Leader, Dr. Riley, is advised
by an Executive Committee of Project and Core Leaders with input from the Scientific Advisory
Committee. The finances and meeting logistics of the U19 will be organized by Ms. Chelsey
Molineaux who will meet monthly with the U19 PI and each Project and Core Leader. Dr. Shaw
will provide comprehensive biostatistics support for the scientific project and core, and for the
design and implementation of the clinical trial. Therefore, the specific aims are:
SA1: To coordinate the interactions among scientists, private sector partners, and NIH
personnel regarding efficient implementation of proposed plans and projects.
SA2: To oversee all budgetary matters, including monitoring of monthly expenses and
preparation of non-competitive renewal applications.
SA3: To provide statistical support for projects, especially the proposed clinical trial in Project 4
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core A: Administrative
-
批准号:10450646
-
项目类别:
-
资助金额:$7.93万
-
财政年份:2020
-
负责人:James L Riley
-
依托单位:
Modeling Combination Immunotherapy for HIV Cure in Humanized Mouse Models
-
批准号:10617364
-
项目类别:
-
资助金额:$97.8万
-
财政年份:2020
-
负责人:James L Riley
-
依托单位:
Modeling Combination Immunotherapy for HIV Cure in Humanized Mouse Models
-
批准号:10450651
-
项目类别:
-
资助金额:$97.41万
-
财政年份:2020
-
负责人:James L Riley
-
依托单位:
Modeling Combination Immunotherapy for HIV Cure in Humanized Mouse Models
-
批准号:9891737
-
项目类别:
-
资助金额:$99.66万
-
财政年份:2020
-
负责人:James L Riley
-
依托单位:
Core A: Administrative
-
批准号:9891733
-
项目类别:
-
资助金额:$8.1万
-
财政年份:2020
-
负责人:James L Riley
-
依托单位:
Core A: Administrative
-
批准号:10617344
-
项目类别:
-
资助金额:$8.15万
-
财政年份:2020
-
负责人:James L Riley
-
依托单位:
Modeling Combination Immunotherapy for HIV Cure in Humanized Mouse Models
-
批准号:10165498
-
项目类别:
-
资助金额:$97.82万
-
财政年份:2020
-
负责人:James L Riley
-
依托单位:
Engineering T cells to Provide Durable Control of HIV-1 Replication
-
批准号:10165491
-
项目类别:
-
资助金额:$280.79万
-
财政年份:2020
-
负责人:James L Riley
-
依托单位:
Engineering T cells to Provide Durable Control of HIV-1 Replication
-
批准号:9891732
-
项目类别:
-
资助金额:$287.15万
-
财政年份:2020
-
负责人:James L Riley
-
依托单位:
Engineering T cells to Provide Durable Control of HIV-1 Replication
-
批准号:10450645
-
项目类别:
-
资助金额:$269.92万
-
财政年份:2020
-
负责人:James L Riley
-
依托单位:
Engineering T cells to Provide Durable Control of HIV-1 Replication
-
批准号:10617343
-
项目类别:
-
资助金额:$242.19万
-
财政年份:2020
-
负责人:James L Riley
-
依托单位:
Engineering T cells to Provide Durable Control of HIV-1 Replication
-
批准号:8899244
-
项目类别:
-
资助金额:$233.51万
-
财政年份:2015
-
负责人:James L Riley
-
依托单位:
Engineering T cells to Provide Durable Control of HIV-1 Replication
-
批准号:9052702
-
项目类别:
-
资助金额:$231.65万
-
财政年份:2015
-
负责人:James L Riley
-
依托单位:
Targeting the Persistent HIV-1 Viral Reservoir Using Engineered T cells
-
批准号:9320900
-
项目类别:
-
资助金额:$46.3万
-
财政年份:2013
-
负责人:James L Riley
-
依托单位:
Targeting the Persistent HIV-1 Viral Reservoir Using Engineered T cells
-
批准号:9109094
-
项目类别:
-
资助金额:$48.0万
-
财政年份:2013
-
负责人:James L Riley
-
依托单位:
Targeting the Persistent HIV-1 Viral Reservoir Using Engineered T cells
-
批准号:8462857
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2013
-
负责人:James L Riley
-
依托单位:
PD-1 signaling in T cells during chronic viral infection
-
批准号:8318855
-
项目类别:
-
资助金额:$49.94万
-
财政年份:2011
-
负责人:James L Riley
-
依托单位:
Restoring HIV-1 Specific T cell Immunity
-
批准号:8062120
-
项目类别:
-
资助金额:$32.2万
-
财政年份:2010
-
负责人:James L Riley
-
依托单位:
Restoring HIV-1 Specific T cell Immunity
-
批准号:8607906
-
项目类别:
-
资助金额:$31.24万
-
财政年份:2010
-
负责人:James L Riley
-
依托单位:
Restoring HIV-1 Specific T cell Immunity
-
批准号:8609393
-
项目类别:
-
资助金额:$8.79万
-
财政年份:2010
-
负责人:James L Riley
-
依托单位:
海外基金